![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Drugmakers Launch Generic Imitrex
Drugmakers Launch Generic Imitrex
August 31, 2009
The FDA has approved nine drugmakers’ ANDAs for generic versions of GlaxoSmith-Kline’s (GSK) migraine treatment Imitrex. Mylan, Sandoz, Dr. Reddy’s Laboratories, Roxane Laboratories, Cobalt Laboratories, Orchid Healthcare, Aurobindo Pharma and Sun Pharmaceutical Industries all received approval for 25-, 50- and 100-mg sumatriptan succinate tablets. Ranbaxy Laboratories won approval for its 25- and 50-mg strengths the same day and will launch the product immediately, according to a recent statement.
Generic Line
Generic Line
Upcoming Events
-
21Oct